🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
LH
NYSE
🇺🇸 US
Labcorp Holdings Inc.
Healthcare
21Score
DipBuster Score™
$281.48
$1.88 (-0.66%)
Live price · Source: Yahoo
52-Week Position
$241.81
76% of range
$293.72
Beta
0.861
Market-like
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.861
52W High$293.72
52W Low$241.81
DipBuster Brief
Key signals at a glance
Zone: Consider Trimming
Neutral
Mid-Range Position (76% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position76% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.861
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at Labcorp Holdings Inc. (LH), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-07-02 | Vaughn Bryan T | SELL | 234 |
| 2026-07-02 | Kyle Kathryn W | SELL | 92 |
| 2026-07-01 | Vaughn Bryan T | SELL | 327 |
| 2026-07-01 | Vaughn Bryan T | SELL | 93 |
| 2026-07-01 | Vaughn Bryan T | BUY | 327 |
| 2026-07-01 | Kyle Kathryn W | SELL | 256 |
| 2026-07-01 | Kyle Kathryn W | SELL | 73 |
| 2026-07-01 | Kyle Kathryn W | BUY | 256 |
| 2026-06-08 | Kyle Kathryn W | SELL | 762 |
| 2026-05-11 | Schechter Adam H | SELL | 5,903 |
Valuation
P/E RatioN/A
Market CapN/A
Beta0.861
Dividend/yrNone
52W High$293.72
52W Low$241.81
52-Week Range
$241.81Now$293.72
76% through annual range
From 52W High−4.2%
From 52W Low+16.4%
📖 Plain English Summary
Labcorp Holdings Inc. is at 76% of its 52-week range. Beta 0.861 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for LH
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — LH
Heuristic · balance sheet, insider filings, price data, academic research
Labcorp Holdings Inc. — DipBuster Score 21/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track Labcorp Holdings Inc. free
Add LH to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
9/25
Momentum & Volume
7/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
2
/100 · NEUTRAL
dip depth
2/25
oversold rsi
0/25
mean reversion
0/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 21/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident …
Sector
Healthcare
Market
🇺🇸 US
CEO
Adam H. Schechter
Staff
71,000 employees
Website